Hudson Executive Capital LP Natera, Inc. Transaction History

Hudson Executive Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $7.19 Million - $10.1 Million	-210,297 Reduced 35.71%	378,589 $15.2 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $5.32 Million - $7.4 Million	61,800 Added 11.72%	588,886 $66.9 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $13.6 Million - $18.5 Million	148,497 Added 39.22%	527,086 $53.5 Million
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $6.72 Million - $10.4 Million	378,589 New	378,589 $10.4 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Hudson Executive Capital LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Executive Capital LP with notifications on news.